Browse all articles >
Correspondence to Editorial on “Targeting TM4SF1 to overcome immunotherapy resistance in hepatocellular carcinoma”
Exploring Methylation Signatures for High De Novo Recurrence Risk in Hepatocellular carcinoma
Targeting TM4SF1 promotes tumor senescence enhancing CD8+ T cell cytotoxic function in hepatocellular carcinoma
Comprehensive analysis of transcriptomic biomarkers for predicting response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma2025 January;31(1)
Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma2023 October;29(4)